Endologix, Inc. Completes Public Offering of Convertible Notes

Represented Endologix (Nasdaq:ELGX) in the public offering of $86 million in convertible notes. Bank of America, Merrill Lynch, and Piper Jaffray were underwriters.

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA).